118 related articles for article (PubMed ID: 37254580)
1. Systematic review and meta-analysis: Prognostic impact of time from diagnosis to treatment in patients with acute myeloid leukemia.
Franco S; Geng X; Korostyshevskiy V; Karp JE; Lai C
Cancer; 2023 Oct; 129(19):2975-2985. PubMed ID: 37254580
[TBL] [Abstract][Full Text] [Related]
2. Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients.
Sekeres MA; Elson P; Kalaycio ME; Advani AS; Copelan EA; Faderl S; Kantarjian HM; Estey E
Blood; 2009 Jan; 113(1):28-36. PubMed ID: 18827183
[TBL] [Abstract][Full Text] [Related]
3. Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Röllig C; Kramer M; Schliemann C; Mikesch JH; Steffen B; Krämer A; Noppeney R; Schäfer-Eckart K; Krause SW; Hänel M; Herbst R; Kunzmann V; Einsele H; Jost E; Brümmendorf TH; Scholl S; Hochhaus A; Neubauer A; Sohlbach K; Fransecky L; Kaufmann M; Niemann D; Schaich M; Frickhofen N; Kiani A; Heits F; Krümpelmann U; Kaiser U; Kullmer J; Wass M; Stölzel F; von Bonin M; Middeke JM; Thiede C; Schetelig J; Berdel WE; Ehninger G; Baldus CD; Müller-Tidow C; Platzbecker U; Serve H; Bornhäuser M
Blood; 2020 Aug; 136(7):823-830. PubMed ID: 32496541
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.
Del Poeta G; Venditti A; Stasi R; Aronica G; Cox MC; Buccisano F; Tamburini A; Bruno A; Maurillo L; Battaglia A; Suppo G; Epiceno AM; Del Moro B; Masi M; Amadori S; Papa G
Leuk Res; 1999 May; 23(5):451-65. PubMed ID: 10374859
[TBL] [Abstract][Full Text] [Related]
5. [Treatment responses, outcomes, and prognostic factors associated with them in patients with secondary acute myeloid leukemia].
Ma L; Zhao T; Chen YY; Jiang H; Xu LP; Zhang XH; Wang Y; Sun YQ; Mo XD; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):124-131. PubMed ID: 36948866
[No Abstract] [Full Text] [Related]
6. Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia.
Bertoli S; Bérard E; Huguet F; Huynh A; Tavitian S; Vergez F; Dobbelstein S; Dastugue N; Mansat-De Mas V; Delabesse E; Duchayne E; Demur C; Sarry A; Lauwers-Cances V; Laurent G; Attal M; Récher C
Blood; 2013 Apr; 121(14):2618-26. PubMed ID: 23365464
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of TdT expression in acute myeloid leukemia with an intermediate-risk karyotype.
Saburi M; Ogata M; Satou T; Soga Y; Itani K; Kohno K; Kondo Y; Nakayama T
Int J Hematol; 2020 Jul; 112(1):17-23. PubMed ID: 32253665
[TBL] [Abstract][Full Text] [Related]
8. Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia.
Ciftciler R; Demiroglu H; Haznedaroglu IC; Sayınalp N; Aksu S; Ozcebe O; Goker H; Aydın MS; Buyukasık Y
Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):729-734. PubMed ID: 31540855
[TBL] [Abstract][Full Text] [Related]
9. [Clinical Efficacy and Survival Analysis of Adult Patients with Acute Myeloid Leukemia after Microtransplantation].
Huang YJ; Zhang JH; Dong CX; Kang JM; Hou YF; Zhang YF; Qi K; Yang LH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1361-1368. PubMed ID: 36208236
[TBL] [Abstract][Full Text] [Related]
10. Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of allogeneic stem-cell transplantation.
Chen Y; Cortes J; Estrov Z; Faderl S; Qiao W; Abruzzo L; Garcia-Manero G; Pierce S; Huang X; Kebriaei P; Kadia T; De Lima M; Kantarjian H; Ravandi F
J Clin Oncol; 2011 Jun; 29(18):2507-13. PubMed ID: 21555694
[TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
Wang R; Gao X; Yu L
BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.
Mao C; Fu XH; Yuan JQ; Yang ZY; Huang YF; Ye QL; Wu XY; Hu XF; Zhai ZM; Tang JL
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010248. PubMed ID: 26544114
[TBL] [Abstract][Full Text] [Related]
13. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ
Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia.
Chang H; Salma F; Yi QL; Patterson B; Brien B; Minden MD
Leuk Res; 2004 Jan; 28(1):43-8. PubMed ID: 14630079
[TBL] [Abstract][Full Text] [Related]
15. Terminal transferase positive acute myeloid leukemia: immunophenotypic characterization and response to induction therapy.
Lo Coco F; Lopez M; Pasqualetti D; Montefusco E; Cafolla A; Monarca B; Sgadari C; De Rossi G
Hematol Oncol; 1989; 7(2):167-74. PubMed ID: 2646199
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of induction efficacy and prognostic factors in FLT3-ITD positive acute myeloid leukemia in the real world].
Jia JS; Zhu HH; Gong LZ; Zhao T; Wang J; Jiang Q; Huang XJ; Jiang H
Zhonghua Xue Ye Xue Za Zhi; 2019 May; 40(5):398-403. PubMed ID: 31207705
[No Abstract] [Full Text] [Related]
17. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
Lee EJ; Yang J; Leavitt RD; Testa JR; Civin CI; Forrest A; Schiffer CA
Leukemia; 1992 Nov; 6(11):1203-9. PubMed ID: 1279324
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features and early treatment effects in intermediate risk and poor risk acute myeloid leukemia with EVI1 positive].
Duan WB; Gong LZ; Jia JS; Zhu HH; Zhao XS; Jiang Q; Zhao T; Wang J; Qin YZ; Huang XJ; Jiang H
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):990-995. PubMed ID: 29263470
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience.
Filì C; Candoni A; Zannier ME; Olivieri J; Imbergamo S; Caizzi M; Nadali G; Di Bona E; Ermacora A; Gottardi M; Facchinelli D; Ciancia R; Lazzarotto D; Dubbini MV; Festini G; Gherlinzoni F; Michieli MG; Semenzato G; Fanin R
Leuk Res; 2019 Jan; 76():33-38. PubMed ID: 30529681
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness analysis of HA based triple-drug regimen as induction chemotherapy in the treatment of acute myeloid leukemia and its relationship with karyotype].
Mi YC; Xue YP; Yu WJ; Liu SH; Zhao YZ; Meng QX; Bian SG; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):705-9. PubMed ID: 16620570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
